BIVI
BIVI
NASDAQ · Biotechnology

Biovie Inc

$1.20
-0.26 (-17.81%)
As of Mar 22, 10:59 PM ET ·
Financial Highlights (FY 2025)
Revenue
9.45M
Net Income
239.2K
Gross Margin
35.8%
Profit Margin
2.5%
Rev Growth
+19.1%
D/E Ratio
0.60
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 35.8% 35.8% 35.8%
Operating Margin 3.3% 3.5% 3.5%
Profit Margin 2.5% 2.9% 2.8%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 9.45M 8.50M 8.91M
Gross Profit 3.38M 3.04M 3.19M
Operating Income 315.3K 300.7K 307.7K
Net Income 239.2K 243.9K 245.4K
Gross Margin 35.8% 35.8% 35.8%
Operating Margin 3.3% 3.5% 3.5%
Profit Margin 2.5% 2.9% 2.8%
Rev Growth +19.1% +23.4% +6.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.36M 2.23M 2.43M
Total Equity 3.96M 4.02M 4.56M
D/E Ratio 0.60 0.55 0.53
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 403.0K 435.3K 434.6K
Free Cash Flow 313.2K 273.2K 249.3K